Kaspersky Lab, which has locations across the globe, develops and sells antivirus software. Under the updated list, no government agency will be able to procure Kaspersky Lab products using a GSA contract.
This week, Bloomberg Businessweek released information linking the company to Russian intelligence. In May, Kaspersky Lab issued a statement saying it had “no ties to any government.”
U.S. officials have not released evidence of a connection between Kaspersky Lab and Russian intelligence, although the FBI is reportedly investigating the company.
“GSA’s priorities are to ensure the integrity and security of U.S. government systems and networks and evaluate products and services available on our contracts using supply chain risk management processes,” a GSA spokesman told The Hill.
The restriction follows the Senate’s push to ban Kaspersky Lab software in a June draft of the fiscal year 2018 Department of Defense budget.
More articles on health IT:
14M Verizon customers’ data exposed, Verizon calls problem “overstated”
AMIA supports federal health IT research and development: 4 recommendations
Health IT Now to FDA: Interoperable PDMPs will curb opioid abuse
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.